Skip navigation

Pfizer Inc.

NYS : PFE
Pharmaceuticals
New York NY
2013 Revenue (US$ Millions)$51,584
2012 Revenue (US$ Millions)$58,986
Revenue Growth (%)-12.55%
Net Income (US$ Millions)$22,003
Common Shares Outstanding (Millions)$6,399
Earnings Per Share (US$)$3.19
Price To Earnings Ratio32.2
Total Equity (US$ Millions)$76,307
Profit Margin (%)42.65%
Return On Equity (%)27.08%
Long Term Debt (US$ Millions)$30,462
Debt To Equity Ratio (%)0.40%
Market Capitalization (US$ Millions)$196,001
Total Assets (US$ Millions)$172,101
Return on Assets (%)11.84
Current Assets (US$ Millions)$56,244
Inventories (US$ Millions)$6,166
Current Liabilities (US$ Millions)$23,366
Cost of Goods Sold (US$ Millions)$9,586
Asset Turnover0.3
Inventory Turnover1.45
ExchangeNYS